Novo Nordisk
NVO
NVO
558 hedge funds and large institutions have $7.89B invested in Novo Nordisk in 2018 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 162 increasing their positions, 199 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
558
Holders Change
+21
Holders Change %
+3.91%
% of All Funds
12.78%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.18%
New
61
Increased
162
Reduced
199
Closed
38
Calls
$78.9M
Puts
$21.7M
Net Calls
+$57.1M
Net Calls Change
+$37.7M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$70.6M |
| 2 |
Two Sigma Investments
New York
|
+$26.3M |
| 3 |
Renaissance Technologies
New York
|
+$24.7M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$21.6M |
| 5 |
Millennium Management
New York
|
+$20.6M |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$27.5M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$27.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$20.8M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$19.8M |
| 5 |
Jane Street
New York
|
-$14.4M |
